Literature DB >> 26460994

Concomitant Imaging Dose and Cancer Risk in Image Guided Thoracic Radiation Therapy.

Yibao Zhang1, Hao Wu1, Zhe Chen2, Jonathan P S Knisely3, Ravinder Nath2, Zhongsu Feng1, Shanglian Bao4, Jun Deng5.   

Abstract

PURPOSE: Kilovoltage cone beam computed tomography (CT) (kVCBCT) imaging guidance improves the accuracy of radiation therapy but imposes an extra radiation dose to cancer patients. This study aimed to investigate concomitant imaging dose and associated cancer risk in image guided thoracic radiation therapy. METHODS AND MATERIALS: The planning CT images and structure sets of 72 patients were converted to CT phantoms whose chest circumferences (Cchest) were calculated retrospectively. A low-dose thorax protocol on a Varian kVCBCT scanner was simulated by a validated Monte Carlo code. Computed doses to organs and cardiac substructures (for 5 selected patients of various dimensions) were regressed as empirical functions of Cchest, and associated cancer risk was calculated using the published models. The exposures to nonthoracic organs in children were also investigated.
RESULTS: The structural mean doses decreased monotonically with increasing Cchest. For all 72 patients, the median doses to the heart, spinal cord, breasts, lungs, and involved chest were 1.68, 1.33, 1.64, 1.62, and 1.58 cGy/scan, respectively. Nonthoracic organs in children received 0.6 to 2.8 cGy/scan if they were directly irradiated. The mean doses to the descending aorta (1.43 ± 0.68 cGy), left atrium (1.55 ± 0.75 cGy), left ventricle (1.68 ± 0.81 cGy), and right ventricle (1.85 ± 0.84 cGy) were significantly different (P<.05) from the heart mean dose (1.73 ± 0.82 cGy). The blade shielding alleviated the exposure to nonthoracic organs in children by an order of magnitude.
CONCLUSIONS: As functions of patient size, a series of models for personalized estimation of kVCBCT doses to thoracic organs and cardiac substructures have been proposed. Pediatric patients received much higher doses than did the adults, and some nonthoracic organs could be irradiated unexpectedly by the default scanning protocol. Increased cancer risks and disease adverse events in the thorax were strongly related to higher imaging doses and smaller chest dimensions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26460994     DOI: 10.1016/j.ijrobp.2015.06.034

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Assessment of female breast dose for thoracic cone-beam CT using MOSFET dosimeters.

Authors:  Wenzhao Sun; Bin Wang; Bo Qiu; Jian Liang; Weihao Xie; Xiaowu Deng; Zhenyu Qi
Journal:  Oncotarget       Date:  2017-03-21

2.  Imaging Dose, Cancer Risk and Cost Analysis in Image-guided Radiotherapy of Cancers.

Authors:  Li Zhou; Sen Bai; Yibao Zhang; Xin Ming; Ying Zhang; Jun Deng
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.996

3.  Estimation of effective imaging dose and excess absolute risk of secondary cancer incidence for four-dimensional cone-beam computed tomography acquisition.

Authors:  Yuki Yuasa; Takehiro Shiinoki; Ryota Onizuka; Koya Fujimoto
Journal:  J Appl Clin Med Phys       Date:  2019-10-08       Impact factor: 2.102

4.  Examining the frequency and concomitant dose of geometric verification imaging for patients undergoing proton beam therapy for ocular tumours; an audit of current clinical practice.

Authors:  Kate Shrewsbury-Gee; Daniel Kelly; Mike Kirby
Journal:  BJR Open       Date:  2021-07-05

5.  Imaging dose and secondary cancer risk in image-guided radiotherapy of pediatric patients.

Authors:  Yvonne Dzierma; Katharina Mikulla; Patrick Richter; Katharina Bell; Patrick Melchior; Frank Nuesken; Christian Rübe
Journal:  Radiat Oncol       Date:  2018-09-05       Impact factor: 3.481

6.  Evaluation of IGRT-Induced Imaging Doses and Secondary Cancer Risk for SBRT Early Lung Cancer Patients In Silico Study.

Authors:  Yan-Hua Duan; Heng-Le Gu; Xiao-Hui Yang; Hua Chen; Hao Wang; Yan Shao; Xiao-Yang Li; Ai-Hui Feng; Yan-Chen Ying; Xiao-Long Fu; Kui Ma; Tao Zhou; Zhi-Yong Xu
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.